Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Why choose QuickDrip
Medicare Advantage (Part C) plans are provided by private insurance companies that are approved by Medicare
The molecule is not well characterized chemically
Injectable GHK-Cu is not FDA-approved for human/therapeutic use and is sold by suppliers under "research use only" labeling
Typical TB500 Dosing Schedule Loading Phase (Weeks 14): Dosage: 48 mg per week Frequency: Split into 2 injections per week (e.g., Monday/Thursday) Goal: Rapid saturation of soft tissue to initiate repair Maintenance Phase (Weeks 58 or longer): Dosage: 26 mg per month Frequency: 1 injection every 714 days Goal: Support long-term recovery and tissue integrity Users typically adjust their dose based on: Injury severity Body weight Co-administration with BPC157 or other peptides Note: These guidelines are based on research chemical protocols and anecdotal data
If you have questions about peptide availability, treatment fit, or documentation, contact Blueline Wellness Group to discuss your goals with our team
US$ 21.66
US$ 24.11
US$ 29.57
US$ 21.95
US$ 22.86
US$ 28.94
US$ 24.06
